Cytomegalovirus

What Is Cytomegalovirus (CMV)?

CMV is a widespread viral infection that most people carry silently. In healthy individuals, it rarely causes illness. After a transplant, however, lowered immunity can allow the virus to reactivate or newly infect the patient. In these situations, CMV can affect the blood, lungs, liver, stomach, or the transplanted organ itself — which is why specialist-led monitoring is critical.
Tailored antiviral treatment

How SSRC Helps You

SSRC’s transplant infectious disease team ensures:

With SSRC’s expertise, CMV becomes a manageable, controlled part of post-transplant care — not a crisis.

Who Is at Risk?

CMV risk increases for:
Patients who received kidney, liver, lung, heart, or bone-marrow transplants
Individuals where the donor is CMV-positive and recipient is CMV-negative
Patients on higher doses of immunosuppressive medications
Those with recent infections or weakened immune responses

Symptoms of CMV

CMV symptoms can range from mild to severe. Common signs include:
If ignored, CMV can progress into significant complications, especially in newly transplanted organs.
Symptoms of CMV
CMV antigen detection

How CMV Is Diagnosed at SSRC

Your SSRC team uses detailed diagnostic tools to catch CMV early:
These tests help determine whether the virus is active, rising, or requires immediate treatment.

Early CMV Care for Safe Transplant Recovery

CMV can reactivate in weakened immune states. SSRC specialists step in early to protect your organ and your health.

immunosuppressive therapy

Treatment Options

Treatment is tailored to the severity of infection and transplant type. SSRC may recommend:
Our approach reduces viral load while protecting your transplanted organ and preventing further complications.

Why Choose SSRC?

SSRC brings a highly specialized, coordinated, and evidence-based approach to transplant infections. With experts like Dr. Gopika Mohan, Dr. Alka Sirohi, and a dedicated clinical team, SSRC ensures comprehensive monitoring and rapid response — safeguarding both your recovery and your transplanted organ. Every plan is individualized, keeping your safety and long-term health at the center.

Dedicated clinical team

Frequently Asked Questions (FAQs)

Yes. CMV can affect the transplanted organ and cause serious complications if untreated, which is why regular monitoring is essential.

Typically weekly during the early months, then less frequently as your recovery stabilizes — depending on your transplant team’s plan.

It can, especially in patients requiring strong immunosuppressive medications. SSRC provides long-term monitoring to prevent recurrence.

Fatigue, fever, abdominal discomfort, and low blood counts. In some cases, symptoms may be minimal — making regular testing important.

Yes. CMV can cause inflammation in the transplanted organ if not controlled, but early treatment at SSRC significantly reduces this risk.

High-risk patients usually receive prophylaxis, while others are monitored closely. SSRC customises this based on donor-recipient CMV status.

Scroll to Top